Fluoropharma Medical
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. The company was founded in 2003 and is headquartered in Montclair, New Jersey.
Fluoropharma Medical (FPMI) - Total Liabilities
Latest total liabilities as of December 2016: $10.51 Million USD
Based on the latest financial reports, Fluoropharma Medical (FPMI) has total liabilities worth $10.51 Million USD as of December 2016.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Fluoropharma Medical - Total Liabilities Trend (2007–2016)
This chart illustrates how Fluoropharma Medical's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Fluoropharma Medical Competitors by Total Liabilities
The table below lists competitors of Fluoropharma Medical ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sienna Biopharmaceuticals Inc
PINK:SNNAQ
|
USA | $20.39 Million |
|
Ba Ria Thermal Power JSC
VN:BTP
|
Vietnam | ₫147.46 Billion |
|
Global Blockchain Acquisition Corp. Warrant
NASDAQ:GBBKW
|
USA | $2.94 Million |
|
MULTISTRADA ARAH SA (QGH.SG)
STU:QGH
|
Germany | €116.72 Million |
|
PRECISE BIOMETRICS (PBCB.SG)
STU:PBCB
|
Germany | €48.67 Million |
Liability Composition Analysis (2007–2016)
This chart breaks down Fluoropharma Medical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 31.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fluoropharma Medical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fluoropharma Medical (2007–2016)
The table below shows the annual total liabilities of Fluoropharma Medical from 2007 to 2016.
| Year | Total Liabilities | Change |
|---|---|---|
| 2016-12-31 | $10.51 Million | +19.00% |
| 2015-12-31 | $8.84 Million | +57.30% |
| 2014-12-31 | $5.62 Million | +88.98% |
| 2013-12-31 | $2.97 Million | +1162.03% |
| 2012-12-31 | $235.51K | -38.09% |
| 2011-12-31 | $380.40K | +550.13% |
| 2010-12-31 | $58.51K | +24.95% |
| 2009-12-31 | $46.83K | +26.15% |
| 2008-12-31 | $37.12K | -4.79% |
| 2007-12-31 | $38.99K | -- |